Finland, Sept. 29 -- Finland based GlaxoSmithKline Oy has secured contract from Markkinaoikeus for Vaccines - Hepatitis B (HBV) vaccine for children and adults 2027-2029 (2029-2030,2030-2031). The value of the contract is worth 2556000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....